Cancer - Krystal Biotech, Inc.

Cancer

Status:

Active, open to accrual

ClinicalTrials.gov:

NCT06228326

A Phase 1 Study of Inhaled KB707 in Patients with Advanced Solid Tumor Malignancies Affecting the Lungs

Drug

KB707

Condition

Advanced Solid Tumor Malignancies Affecting the Lungs